ZIMMER BIOMET HLDGS DL-01
ZIMMER BIOMET HLDGS DL-01/ US98956P1021 /
ZIM
|
16/08/2024 08:04:18
|
Chg.
-0.120
|
Volume |
Bid19:06:14 |
Demandez à19:06:14 |
Capitalisation boursière |
Dividende Y. |
Rapport P/E |
|
99.680EUR
|
-0.12%
|
-
Chiffrre d'affaires: - |
100.450Bid taille: 1,000 |
100.750Ask la taille: 1,000 |
20.55 Mrd.EUR |
- |
- |
Description de l'entreprise
Founded in 1927 and headquartered in Warsaw, Indiana, USA, Zimmer Biomet is a global leader in musculoskeletal healthcare. The company designs, manufactures and markets orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products.
Conseil d'administration & Conseil de surveillance
| PDG |
| Ivan Tornos |
| Conseil d'administration |
| Suketu Upadhyay, Mark Bezjak, Rachel Ellingson, Nitin Goyal, David J. Kunz, Angela Main, Keri P. Mattox, Chad Phipps, Paul Stellato, Zeeshan Tariq, Kenneth R. Tripp, Lori Winkler, Sang Yi, Wilfred van Zuilen |
| Conseil de surveillance |
| Christopher B. Begley, Betsy J. Bernard, Michael J. Farrell, Robert A. Hagemann, Ivan Tornos, Arthur J. Higgins, Maria Teresa Hilado, Syed Jafry, Sreelakshmi Kolli, Michael W. Michelson |
Données de l'entreprise
| Nom: |
Zimmer Biomet Holdings Inc. |
| Adresse: |
345 East Main Street,Warsaw, Indiana 46580, USA |
| Téléphone: |
+1-574-373-3121 |
| Fax: |
- |
| Courriel: |
surveys@zimmerbiomet.com
|
| Internet: |
www.zimmerbiomet.com/ |
| Industrie: |
Healthcare |
| Secteur: |
Medical Products |
| Sous-secteur: |
Advanced Medical Devices |
| Fin de l'exercice financier: |
31/12 |
| Flotte libre: |
74.90% |
| IPO date: |
03/08/2001 |
